Core Insights - Stereotaxis has successfully completed the world's first procedures using MAGiC Sweep™, a robotically-navigated high-density electrophysiology mapping catheter, marking a significant advancement in surgical robotics for minimally invasive endovascular interventions [1][2]. Company Overview - Stereotaxis is a pioneer and global leader in innovative surgical robotics, focusing on minimally invasive endovascular interventions. The company aims to enhance patient care through robotic precision and safety, while also expanding access to such therapies [3]. - The technology developed by Stereotaxis has been utilized to treat over 150,000 patients globally, including regions such as the United States, Europe, and Asia [3]. Product Launch and Regulatory Status - Following FDA clearance, Stereotaxis has initiated the commercial launch of MAGiC Sweep in the United States, with plans for regulatory clearance in Europe [2].